ApolloBio Corp. has acquired Inovio Pharmaceuticals Inc.
|Inovio Pharmaceuticals Inc.|
|Description||Inovio will immediately receive $23 million in upfront payment; an additional $20 million in future regulatory milestone payments and double-digit tiered royalties on future sales.|
|Global M&A Offices||
Hollyhigh International Capital (Global M&A China)
|Global M&A Advisory||Advisor to the seller|